By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


bluebird bio 

840 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-491-5601 Fax: 617-576-2421


Key Statistics

Ownership: Public

Web Site: bluebird bio
Symbol: BLUE


Gene Therapy

Company News
bluebird bio (BLUE) Reports Second Quarter 2017 Financial Results And Recent Operational Progress 8/3/2017 8:04:02 AM
bluebird bio (BLUE) Eyes $350 Million Public Offering of Common Stock 6/28/2017 6:46:02 AM
bluebird bio (BLUE) Announces Topline Interim Clinical Data From Starbeam Study Of Lenti-D Drug Product In Cerebral Adrenoleukodystrophy (CALD) 6/27/2017 7:10:47 AM
bluebird bio (BLUE) Presents New Data From HGB-205 Study Of LentiGlobin Drug Product In Patients With Transfusion-Dependent ?-Thalassemia (TDT) And Severe Sickle Cell Disease (SCD) At European Hematology Association Annual Meeting 6/23/2017 6:51:18 AM
bluebird bio (BLUE) Announces Early Data From Phase III Northstar-2 (HGB-207) Study Of LentiGlobin Drug Product At European Hematology Association Annual Meeting 6/23/2017 6:46:43 AM
bluebird bio (BLUE) Touts Impressive Data From Late-Stage Gene Therapy Study 6/23/2017 5:45:26 AM
bluebird bio (BLUE) Appoints John O. Agwunobi, M.D. And Douglas A. Melton, Ph.D. To Board Of Directors 6/9/2017 6:36:10 AM
Investors Sigh With Relief as bluebird bio (BLUE), Celgene (CELG)'s CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free 6/5/2017 5:59:44 AM
bluebird bio (BLUE) Announces Collaboration With Duke University’s Robert J. Margolis, MD, Center For Health Policy On Value-Based Payment Framework For Gene Therapy 5/23/2017 9:58:11 AM
bluebird bio (BLUE) To Present New Data From Lentiglobintm Clinical Studies At European Hematology Association (EHA) Annual Meeting 5/18/2017 7:36:14 AM